|
 Home: PCU 3|2004: Joel Picus, MD: Select publications
Select publication
Picus J et al. The use of bevacizumab (B) with docetaxel (D) and estramustine (E) in hormone refractory prostate cancer (HRPC): Initial results of CALGB 90006. Proc ASCO 2003;Abstract 1578.
|
|
|
|
|
|
|
|
|
|
